Recent thymic emigrants in lymphoma patients with and without human immunodeficiency virus infection candidates for autologous peripheral stem cell transplantation

C. Pratesi, C. Simonelli, S. Zanussi, R. Talamini, M. T. Bortolin, R. Tedeschi, A. Marus, C. Caffau, M. Michieli, U. Tirelli, P. De Paoli

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Signal joint T cell receptor excision circles (sjTRECs) have been reported as a clinical marker to measure the potential for recovery of the immune system after immunosuppressive treatments. The aim of this study was to investigate the thymic regenerative potential in 55 human immunodeficiency virus (HIV)-1 infected (HIV+) and non-infected (HIV-) lymphoma patients, candidates for autologous stem cell transplantation (ASCT). Moreover, the possible associations between sjTRECs and other immunological and clinical parameters were examined. SjTRECs levels in peripheral blood mononuclear cells (PBMCs) were quantified by real-time polymerase chain reaction and T lymphocyte subsets were analysed by flow cytometry. Our data showed that sjTRECs were reduced in lymphoma patients compared to healthy controls, although a weak significant association between low sjTRECs levels and increasing age was maintained [odds ratio (OR) = 4.00; 95% confidence interval (CI) 1.09-17.17]. We found that different chemotherapeutic treatments seem to induce similar effects on the thymic reservoir, independently from their intensity (type and number of cycles of previous chemotherapy). Results from multivariate models including adjustment for patients' sex, type of lymphoma and type of chemotherapy showed that thymic output was independent from HIV infection (OR, 0.95; 95% CI 0.20-4.48). SjTRECs levels correlated with naive T cell subsets in overall lymphoma patients and after stratification by HIV infection (r > 0.37). HIV replication should be maximally suppressed to properly evaluate thymic output by sjTREC markers. Our results suggested that de novo T cell generation is maintained partially in pretreated recurrent lymphoma patients, candidates for ASCT, and could contribute to restore the immune function after transplantation.

Original languageEnglish
Pages (from-to)101-109
Number of pages9
JournalClinical and Experimental Immunology
Volume151
Issue number1
DOIs
Publication statusPublished - Jan 2008

Fingerprint

Peripheral Blood Stem Cell Transplantation
Virus Diseases
T-Cell Antigen Receptor
Lymphoma
Joints
HIV
T-Lymphocyte Subsets
Stem Cell Transplantation
Odds Ratio
Confidence Intervals
Drug Therapy
Immunosuppressive Agents
Virus Replication
HIV-1
Real-Time Polymerase Chain Reaction
Immune System
Blood Cells
Flow Cytometry
Transplantation
Biomarkers

Keywords

  • Autologous stem cell transplantation
  • HIV infection
  • Recurrent lymphoma
  • TCR excision circles

ASJC Scopus subject areas

  • Immunology

Cite this

Recent thymic emigrants in lymphoma patients with and without human immunodeficiency virus infection candidates for autologous peripheral stem cell transplantation. / Pratesi, C.; Simonelli, C.; Zanussi, S.; Talamini, R.; Bortolin, M. T.; Tedeschi, R.; Marus, A.; Caffau, C.; Michieli, M.; Tirelli, U.; De Paoli, P.

In: Clinical and Experimental Immunology, Vol. 151, No. 1, 01.2008, p. 101-109.

Research output: Contribution to journalArticle

Pratesi, C. ; Simonelli, C. ; Zanussi, S. ; Talamini, R. ; Bortolin, M. T. ; Tedeschi, R. ; Marus, A. ; Caffau, C. ; Michieli, M. ; Tirelli, U. ; De Paoli, P. / Recent thymic emigrants in lymphoma patients with and without human immunodeficiency virus infection candidates for autologous peripheral stem cell transplantation. In: Clinical and Experimental Immunology. 2008 ; Vol. 151, No. 1. pp. 101-109.
@article{f52f8cbb826147dd8ea5d2012671f6c7,
title = "Recent thymic emigrants in lymphoma patients with and without human immunodeficiency virus infection candidates for autologous peripheral stem cell transplantation",
abstract = "Signal joint T cell receptor excision circles (sjTRECs) have been reported as a clinical marker to measure the potential for recovery of the immune system after immunosuppressive treatments. The aim of this study was to investigate the thymic regenerative potential in 55 human immunodeficiency virus (HIV)-1 infected (HIV+) and non-infected (HIV-) lymphoma patients, candidates for autologous stem cell transplantation (ASCT). Moreover, the possible associations between sjTRECs and other immunological and clinical parameters were examined. SjTRECs levels in peripheral blood mononuclear cells (PBMCs) were quantified by real-time polymerase chain reaction and T lymphocyte subsets were analysed by flow cytometry. Our data showed that sjTRECs were reduced in lymphoma patients compared to healthy controls, although a weak significant association between low sjTRECs levels and increasing age was maintained [odds ratio (OR) = 4.00; 95{\%} confidence interval (CI) 1.09-17.17]. We found that different chemotherapeutic treatments seem to induce similar effects on the thymic reservoir, independently from their intensity (type and number of cycles of previous chemotherapy). Results from multivariate models including adjustment for patients' sex, type of lymphoma and type of chemotherapy showed that thymic output was independent from HIV infection (OR, 0.95; 95{\%} CI 0.20-4.48). SjTRECs levels correlated with naive T cell subsets in overall lymphoma patients and after stratification by HIV infection (r > 0.37). HIV replication should be maximally suppressed to properly evaluate thymic output by sjTREC markers. Our results suggested that de novo T cell generation is maintained partially in pretreated recurrent lymphoma patients, candidates for ASCT, and could contribute to restore the immune function after transplantation.",
keywords = "Autologous stem cell transplantation, HIV infection, Recurrent lymphoma, TCR excision circles",
author = "C. Pratesi and C. Simonelli and S. Zanussi and R. Talamini and Bortolin, {M. T.} and R. Tedeschi and A. Marus and C. Caffau and M. Michieli and U. Tirelli and {De Paoli}, P.",
year = "2008",
month = "1",
doi = "10.1111/j.1365-2249.2007.03516.x",
language = "English",
volume = "151",
pages = "101--109",
journal = "Clinical and Experimental Immunology",
issn = "0009-9104",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Recent thymic emigrants in lymphoma patients with and without human immunodeficiency virus infection candidates for autologous peripheral stem cell transplantation

AU - Pratesi, C.

AU - Simonelli, C.

AU - Zanussi, S.

AU - Talamini, R.

AU - Bortolin, M. T.

AU - Tedeschi, R.

AU - Marus, A.

AU - Caffau, C.

AU - Michieli, M.

AU - Tirelli, U.

AU - De Paoli, P.

PY - 2008/1

Y1 - 2008/1

N2 - Signal joint T cell receptor excision circles (sjTRECs) have been reported as a clinical marker to measure the potential for recovery of the immune system after immunosuppressive treatments. The aim of this study was to investigate the thymic regenerative potential in 55 human immunodeficiency virus (HIV)-1 infected (HIV+) and non-infected (HIV-) lymphoma patients, candidates for autologous stem cell transplantation (ASCT). Moreover, the possible associations between sjTRECs and other immunological and clinical parameters were examined. SjTRECs levels in peripheral blood mononuclear cells (PBMCs) were quantified by real-time polymerase chain reaction and T lymphocyte subsets were analysed by flow cytometry. Our data showed that sjTRECs were reduced in lymphoma patients compared to healthy controls, although a weak significant association between low sjTRECs levels and increasing age was maintained [odds ratio (OR) = 4.00; 95% confidence interval (CI) 1.09-17.17]. We found that different chemotherapeutic treatments seem to induce similar effects on the thymic reservoir, independently from their intensity (type and number of cycles of previous chemotherapy). Results from multivariate models including adjustment for patients' sex, type of lymphoma and type of chemotherapy showed that thymic output was independent from HIV infection (OR, 0.95; 95% CI 0.20-4.48). SjTRECs levels correlated with naive T cell subsets in overall lymphoma patients and after stratification by HIV infection (r > 0.37). HIV replication should be maximally suppressed to properly evaluate thymic output by sjTREC markers. Our results suggested that de novo T cell generation is maintained partially in pretreated recurrent lymphoma patients, candidates for ASCT, and could contribute to restore the immune function after transplantation.

AB - Signal joint T cell receptor excision circles (sjTRECs) have been reported as a clinical marker to measure the potential for recovery of the immune system after immunosuppressive treatments. The aim of this study was to investigate the thymic regenerative potential in 55 human immunodeficiency virus (HIV)-1 infected (HIV+) and non-infected (HIV-) lymphoma patients, candidates for autologous stem cell transplantation (ASCT). Moreover, the possible associations between sjTRECs and other immunological and clinical parameters were examined. SjTRECs levels in peripheral blood mononuclear cells (PBMCs) were quantified by real-time polymerase chain reaction and T lymphocyte subsets were analysed by flow cytometry. Our data showed that sjTRECs were reduced in lymphoma patients compared to healthy controls, although a weak significant association between low sjTRECs levels and increasing age was maintained [odds ratio (OR) = 4.00; 95% confidence interval (CI) 1.09-17.17]. We found that different chemotherapeutic treatments seem to induce similar effects on the thymic reservoir, independently from their intensity (type and number of cycles of previous chemotherapy). Results from multivariate models including adjustment for patients' sex, type of lymphoma and type of chemotherapy showed that thymic output was independent from HIV infection (OR, 0.95; 95% CI 0.20-4.48). SjTRECs levels correlated with naive T cell subsets in overall lymphoma patients and after stratification by HIV infection (r > 0.37). HIV replication should be maximally suppressed to properly evaluate thymic output by sjTREC markers. Our results suggested that de novo T cell generation is maintained partially in pretreated recurrent lymphoma patients, candidates for ASCT, and could contribute to restore the immune function after transplantation.

KW - Autologous stem cell transplantation

KW - HIV infection

KW - Recurrent lymphoma

KW - TCR excision circles

UR - http://www.scopus.com/inward/record.url?scp=36849040080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36849040080&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2249.2007.03516.x

DO - 10.1111/j.1365-2249.2007.03516.x

M3 - Article

VL - 151

SP - 101

EP - 109

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

IS - 1

ER -